Evidence map›Paper›PMID 42589701›Full record

ReviewInternational journal of molecular sciences2026

SASH1 as a Context-Dependent Multi-Docking Scaffold Linking Receptor Signaling to Cytoskeletal Dynamics.

Christopher M Clements, Md Saiful Islam Roney, Yiqun G Shellman

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christopher M ClementsDepartment of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0002-3404-1797
Md Saiful Islam RoneyDepartment of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0003-3575-6281
Yiqun G ShellmanDepartment of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0003-0598-5753

Funding

Training in Translational Research of Skin DiseasesT32AR007411 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI ASGARI, MARYAM MANDANA, ROOP, DENNIS · 1986 to 2025
$4.8M
Study of melanocyte lineage through SASH1 and associated proteinsR01AR074420 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI SHELLMAN, YIQUN G · 2020 to 2024
$2.2M
Predoctoral Training in the Physiology of Human Health and Disease (PHHD)T32GM159536 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI Mary CM Weiser-Evans · 2025 to 2026
$343k
BLRD VA I01 BX000141NIAMS NIH HHS 3R01AR074420-05S1NIAMS NIH HHS 5T32AR007411-40NIAMS NIH HHS R01 AR074420NIAMS NIH HHS R01AR074420NIAMS NIH HHS T32 AR007411NIGMS NIH HHS GM159536NIGMS NIH HHS T32 GM159536United States Department of Veterans Affairs BX000141
6 · The paper itself

Abstract

SASH1 (SAM [sterile alpha motif] and SH3 [SRC-homology-3] domain-containing protein 1) is a multidomain scaffold implicated in pigmentation, innate immunity, receptor signaling, cytoskeletal dynamics, vascular biology, and tumor suppression. Although genetic and expression studies link SASH1 dysfunction to diverse diseases, a unifying mechanistic framework has remained elusive. Here, we synthesize current knowledge of SASH1 structure, interaction networks, and biological functions across cell types and disease contexts. SASH1 contains an intrinsically disordered SPIDER (SLy Proteins Associated Disordered Region), an SH3 domain, two SAM domains, and multiple linear motifs; together, these elements mediate interactions with EphA8 (ephrin type-A receptor 8), β-arrestin 1, TRAF6 (TNF receptor-associated factor 6), CRKL (CRK-like proto-oncogene), IQGAP1 (IQ-motif-containing GTPase-activating protein 1), cortactin, and TNKS2 (tankyrase-2). We propose that SASH1 functions as a context-dependent multi-docking scaffold that organizes signaling architecture. Its modular domains, intrinsically disordered regions, and dual SAM domains enable flexible, multivalent interactions with partners that can be grouped into three functional modules: receptor regulation, intracellular signaling, and cytoskeletal organization. Notably, many SASH1 partners are themselves scaffold or adaptor proteins, allowing integration into pre-existing networks in a hierarchical 'scaffold-of-scaffolds' manner. Through selective partner recruitment, SASH1 links cell-surface receptor inputs to downstream signaling pathways and cytoskeletal remodeling. This model provides a mechanistic framework for how SASH1 drives diverse, cell-type-specific outputs across physiology and disease, while revealing broader principles by which multidomain scaffolds encode cellular behavior.

Indexed as

CytoskeletonSignal TransductionTumor Suppressor ProteinsAnimalsHumansProtein BindingProto-Oncogene MasMAS1 protein, humanProto-Oncogene MasSASH1 protein, humanTumor Suppressor Proteinspigmentation disordersSASH1-associated pigmentary diseases (SAPD)SASH1 (SAM and SH3 domain-containing protein 1)scaffold proteinSLy proteins associated disordered region (SPIDER)SRC-homology-3 (SH3) domainsterile alpha motif (SAM) domaintankyrasetumor suppressor

Identifiers

PMID42589701
PMCPMC13467429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.